Accumulating evidence has shown that ILF3 is abnormally expressed in a series of malignancies, and is involved in tumor proliferation, metastasis, and invasion (Hu et al., 2013; Jiang et al., 2015; Liu et al., 2019). Here, ILF3 is linked to neoplasm.